ArticleScientific reports2026
In planta engineering of polysialylated glycoproteins using salmonid polysialyltransferases.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Polysialic acid (polySia) is a glycan polymer composed of a linear chain of sialic acid residues detected on a small set of proteins in mammalian cells. This negatively charged glycan modulates various cellular functions and has potential biomedical applications. However, the targeted synthesis of polySia remains challenging due to biosynthetic and structural complexity. In this study, we investigated three polysialyltransferases from the salmonid Coregonus maraena (Cma-ST8Sia) for their application in glycoengineering. For this, the corresponding genes Cmast8Sia2-R1, Cmast8Sia2-R2, and Cmast8Sia4 were transiently expressed in Nicotiana benthamiana, and confocal laser scanning microscopy of GFP-fused Cma-ST8Sia exhibited trans-Golgi localization. Co-expression of Cma-ST8Sia with genes from the mammalian sialic acid biosynthesis pathway resulted in autopolysialylation of CmaST8SiaII-R1 and CmaST8SiaIV, but not of CmaST8SiaII-R2. Furthermore, co-expression with glycoproteins demonstrated polysialylation of recombinant proteins with distinct efficiencies and chain lengths. Inactive EndoN-coupled resin was used to enrich polysialylated proteins, and by the application of HPLC/DMB labeling, a degree of polymerization up to 45 was determined. Finally, a microglia inhibition assay demonstrated the biological activity of the engineered polySia. Collectively, these findings advance the capacity to engineer high-quality polySia in an eco-friendly, sustainable system, facilitating in-depth studies and the rational design of complex glycans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.